IP for Value Creation in Biotechnology
22 March 2007 - 24 March 2007
Spain
The courses will consist of four modules covering the following themes: Basic Business Essentials of Biotechnology; IP, Licensing and the Pipeline for Value Creation; Biotech Financing, Partnering, M&As and Strategic alliances and Clinical Trial Strategy and Regulatory Approval.
The upcoming module will cover the basics of patent law, the development of a strong patent portfolio and the importance of industry versus patents. SIMS intends to teach students basic skills including how to build a pipeline for creative value, how to sell and buy IP and how to choose the right IP strategy as well as exposing participating scientists and companies to new research and business opportunities, giving them a better understanding of the technology markets and the technological value chains. The faculty of experts will include Mrs. Margaret Beer, Director and Scientific Liaison at Merck, Mrs. Nancy Levi, the President of Bio-Health Management in Boston, Mr. Jorn Roland Muller, partner at Vossius and Partner and Mrs. Denise Hirsch, Director of IP at INSERM in Paris. The Programme Director will be Mr. José Carlos Gutiérrez-Ramos, Vice-President of R&D at San Francisco-based Avidia, and former Vice President for Inflammation at Millennium Pharmaceuticals.
The first module of the course, “Basic Business Essentials of Biotechnology”, took place in Barcelona from 29 June – 1 July 2006, bringing together 10 industry experts and 24 participants, over two thirds of whom stated that they would actively recommend the course. One of the attendees, Fouzia Laghrissi of the Roche Licensing department claimed that “It was a great pleasure to contribute to the course. This has been an enjoyable and good learning experience.”
For more information please contact:
Mr. José Carlos Gutiérrez-Ramos
Balmes, 132
08008 Barcelona,
Spain
T: +34 93 542 18 50
F: +34 93 542 18 08
Email: info@idec.upf.edu
Registration is available at:
http://www.idec.upf.edu/sims2/(opens in new window)
About SIMS:
SIMS is a joint initiative of the Economics Department of the Pompeu Fabra University (UPF) and the Barcelona Biomedical Research Park (PRBB) and hopes to create a world-class framework in Barcelona for learning and a knowledge centre for entrepreneurship and innovation for new emerging technologies, predominantly in the field of biotechnology. The SIMS Executive Courses are sponsored by the Bioregion of Catalonia and the BBVA foundation. SIMS is a learning platform between companies, technology regions and academia for exchanging experiences, information, good practices and knowledge, specialising in case-based studies that are directly applicable to the European Biotechnology sector.
For more information on the Barcelona Biomedical Research Park please visit:
http://www.prbb.org/(opens in new window)
For more information on the Pompeu Fabra University please visit:
http://www.upf.edu/(opens in new window)
For more information on the Bioregion of Catalonia please visit:
http://www.bioregiocat.net/(opens in new window)
The upcoming module will cover the basics of patent law, the development of a strong patent portfolio and the importance of industry versus patents. SIMS intends to teach students basic skills including how to build a pipeline for creative value, how to sell and buy IP and how to choose the right IP strategy as well as exposing participating scientists and companies to new research and business opportunities, giving them a better understanding of the technology markets and the technological value chains. The faculty of experts will include Mrs. Margaret Beer, Director and Scientific Liaison at Merck, Mrs. Nancy Levi, the President of Bio-Health Management in Boston, Mr. Jorn Roland Muller, partner at Vossius and Partner and Mrs. Denise Hirsch, Director of IP at INSERM in Paris. The Programme Director will be Mr. José Carlos Gutiérrez-Ramos, Vice-President of R&D at San Francisco-based Avidia, and former Vice President for Inflammation at Millennium Pharmaceuticals.
The first module of the course, “Basic Business Essentials of Biotechnology”, took place in Barcelona from 29 June – 1 July 2006, bringing together 10 industry experts and 24 participants, over two thirds of whom stated that they would actively recommend the course. One of the attendees, Fouzia Laghrissi of the Roche Licensing department claimed that “It was a great pleasure to contribute to the course. This has been an enjoyable and good learning experience.”
For more information please contact:
Mr. José Carlos Gutiérrez-Ramos
Balmes, 132
08008 Barcelona,
Spain
T: +34 93 542 18 50
F: +34 93 542 18 08
Email: info@idec.upf.edu
Registration is available at:
http://www.idec.upf.edu/sims2/(opens in new window)
About SIMS:
SIMS is a joint initiative of the Economics Department of the Pompeu Fabra University (UPF) and the Barcelona Biomedical Research Park (PRBB) and hopes to create a world-class framework in Barcelona for learning and a knowledge centre for entrepreneurship and innovation for new emerging technologies, predominantly in the field of biotechnology. The SIMS Executive Courses are sponsored by the Bioregion of Catalonia and the BBVA foundation. SIMS is a learning platform between companies, technology regions and academia for exchanging experiences, information, good practices and knowledge, specialising in case-based studies that are directly applicable to the European Biotechnology sector.
For more information on the Barcelona Biomedical Research Park please visit:
http://www.prbb.org/(opens in new window)
For more information on the Pompeu Fabra University please visit:
http://www.upf.edu/(opens in new window)
For more information on the Bioregion of Catalonia please visit:
http://www.bioregiocat.net/(opens in new window)